Geneos Wealth Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$7K 2524
2022
Q2
$7K Hold
100
﹤0.01% 2100
2022
Q1
$7K Hold
100
﹤0.01% 2249
2021
Q4
$9K Hold
100
﹤0.01% 2235
2021
Q3
$12K Buy
+100
New +$14K ﹤0.01% 2158
2021
Q2
Sell
-32
Closed -$4K 3097
2021
Q1
$4K Buy
+32
New +$3.2K ﹤0.01% 2746

Other funds holding STAA

Geneos Wealth Management's STAA Position: Q3 2022 in Review

Geneos Wealth Management sold out of STAAR Surgical (STAA) in Q3 2022, closing a stake of 100 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in STAA in Q1 2021 and held it in 5 quarters. The position peaked at $12K in Q3 2021. 304 funds tracked by Wall St. Rank hold STAA as of Q3 2022.

  • Geneos Wealth Management reported no remaining STAAR Surgical position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 100 STAAR Surgical shares in Q3 2022, an estimated $7K.
  • Geneos Wealth Management first reported a position in STAAR Surgical in Q1 2021 and held it in 5 quarters.
  • Geneos Wealth Management's STAAR Surgical position peaked at $12K in Q3 2021.
  • 304 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.